AbbVie Inc. (ABBV)

152.7 -0.45%
Sep 24 close; Powered by Koyfin
Pros
Company’s profitability is improving
Forward dividend yield higher than the industry and sector averages
Forward P/E ratio low relative to industry peers
Forward P/B ratio low relative to industry peers
Forward P/S ratio low relative to industry peers
Buy analyst rating
Average analyst stock price above current stock price
Cons
Revenue growth lower than the industry and sector averages
High short interest

Pros

  1. ABBV profitability is improving. The YoY profit margin change was 0.09 percentage points. See ABBV profitability chart.
  2. ABBV forward dividend yield is 4.03%, higher than the industry (2.30%) and sector (0.23%) forward dividend yields. See ABBV forward dividend chart.
  3. ABBV forward P/E ratio is 13.40, which is low compared to its industry peers’ P/E ratios. See ABBV forward P/E ratio chart.
  4. ABBV Price/Book ratio is 20.33, which is low compared to its industry peers’ P/B ratios. See ABBV forward Price/Book ratio chart.
  5. ABBV Price/Sales ratio is 4.67, which is low compared to its industry peers’ P/S ratios. See ABBV forward Price/Sales ratio chart.
  6. ABBV average analyst rating is Buy. See ABBV analyst rating chart.
  7. ABBV average analyst price target ($167.60) is above its current price ($148.20). See ABBV price target chart.

Cons

  1. ABBV quarterly revenue growth was -4.90%, lower than the industry and sector average revenue growth (5.10% and 2.15%, respectively). See ABBV revenue growth chart.
  2. ABBV short interest (days to cover the shorts) ratio is 2.53. The stock garners more short interest than the average industry, sector or S&P 500 stock. See ABBV short interest ratio chart.